21 research outputs found
The estimation of the direct and indirect effect of stroke on MCS & PCS (Bootstrap resamples: 5000).
<p>Footnote: Controlling covariates: Age, sex, body mass index, education, living status, smoking, drinking, diabetes, hypertension, cardiovascular disease, hyperlipidemia, and PCS (or MCS). MCS: mental component score, PCS: physical component score, (): bias-corrected and accelerated 95% confidence interval. Bolded lines indicate significant direct and indirect effects.</p
Multiple regression analysis for factors associated with health-related quality of life among the elderly in Yilan from 2011–2012.
<p>Multiple regression analysis for factors associated with health-related quality of life among the elderly in Yilan from 2011–2012.</p
Anxiety and Depression Mediate the Health-Related Quality of Life Differently in Patients with Cardiovascular Disease and Stroke–Preliminary Report of the Yilan Study: A Population-Based Community Health Survey
<div><p>Background</p><p>Cardiovascular disease and stroke have emerged as substantial and growing health challenges to populations around the world. Besides for the survival and medical prognosis, how to improve the health-related quality of life (HRQoL) might also become one of the goals of treatment programs. There are multiple factors that influence HRQol, including comorbidity, mental function and lifestyle. However, substantial research and investigation have still not clarified these underlying pathways, which merit further attention. The purpose of this study was to determine how psychological factors affect the link between cardiovascular disease and stroke with HRQoL.</p><p>Methods and Result</p><p>A total of 1,285 elder subjects at least 65 years of age (47.2% male) were enrolled. The mental function and HRQol of each patient was then measured using the Hospital Anxiety and Depression Scale and Short Form-12. After multiple regression analysis, anxiety, depression, cardiovascular disease, stroke, education level and age were shown to be associated with both mental component score (MCS) and physical component score (PCS). In the mediation analysis using the SPSS macro provided by Preacher and Hayes, cardiovascular disease and stroke affected HRQoL via anxiety and depression, respectively.</p><p>Conclusions</p><p>These results suggest that cardiovascular disease and stroke have negative impacts on patient MCS and PCS through different underlying pathways. Cardiovascular disease influences the HRQoL both directly and indirectly with the mediation of anxiety, and stroke influences the HRQoL by way of depression. These findings support the proposition that different combinations of both physical and psychological support are necessary to best manage these diseases.</p></div
The estimation of the direct and indirect effect of cardiovascular disease on MCS & PCS (Bootstrap resamples: 5000).
<p>Footnote: Controlling covariates: Age, sex, body mass index, education, living status, smoking, drinking, diabetes, hypertension, hyperlipidemia, stroke, and PCS (or MCS). MCS: mental component score, PCS: physical component score, (): bias-corrected and accelerated 95% confidence interval. Bolded lines indicate significant direct and indirect effects.</p
ROC curve for the ADMA levels in predicting adverse events.
<p>The area under the curve for ADMA levels in predicting adverse events was 0.767 (95% confidence interval  =  0.654–0.879). ADMA  =  asymmetric dimethylarginine; ROC curve  =  receiver-operator characteristics curve.</p
ADMA levels in AF and non-AF patients.
<p>The ADMA levels were higher in AF patients compared to non-AF patients. In addition, non-PAF patients had higher levels of ADMA than PAF patients. ADMA  =  asymmetric dimethylarginine; AF  =  atrial fibrillation; PAF  =  paroxysmal atrial fibrillation. *P value <0.05, PAF or non-PAF versus no AF. <sup>+</sup>P value <0.05, Non-PAF versus PAF.</p
Univariate Cox regression analysis for predictors of adverse events.
<p>ADMA  =  asymmetric dimethylarginine; LVEF  =  left ventricular ejection fraction.</p
Event-free survival curve for patients with different ADMA levels.
<p>Kaplan-Meier survival analysis showed that the patients with an ADMA level ≥ 0.55 µmol/L were associated with a higher event rate compared to patients with an ADMA level <0.55 µmol/L (33.3% versus 9.3%, p = 0.001). ADMA  =  asymmetric dimethylarginine.</p
Noncontact mapping findings of triggers.
<p>BO = breakout; EA = earliest activation; Eg = electrogram; PNV = peak negative value; Other abbreviations are the same as <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0140167#pone.0140167.t001" target="_blank">Table 1</a>.</p><p>Noncontact mapping findings of triggers.</p
Baseline Clinical Characteristics of 35 Patients.
<p>* Measured by ventriculogram</p><p><sup>†</sup> Data are presented as median (range).</p><p>ARVC = arrhythmogenic right ventricular cardiomyopathy; ICD = implantable cardioverter-defibrillator; LVEF = left ventricular ejection fraction; NS = nonsignificant; PVC = premature ventricular contraction; RVEF = right ventricular ejection fraction; RVOT = right ventricular outflow tract; VT = ventricular tachycardia.</p><p>Baseline Clinical Characteristics of 35 Patients.</p